{"content":[{"text":"IFMSA Policy Document \n HPV Vaccines","bbox":{"left":0.326185,"top":0.142565,"width":0.347566,"height":0.05408099999999999}},{"text":"Proposed by LeMSIC-Lebanon and SfGH-United Kingdom \n Adopted at the IFMSA General Assembly March Meeting 2019, in Portorož, Slovenia.","bbox":{"left":0.12105,"top":0.228658,"width":0.738576,"height":0.03286999999999998}},{"text":"Policy Statement \n Introduction: \n Human papillomavirus (HPV) is a sexually transmitted infection that leads to a range of conditions, \n including the development of secondary non-communicable diseases such as cervical, throat and anal \n cancers. It is responsible for 4.5% of the worldwide cancer burden, and 7.5% of all female cancer \n deaths. HPV vaccination, along with early detection and treatment of HPV-associated disease, could \n prevent almost all cervical cancer cases, and eventually lead to the elimination of HPV. Many countries \n have introduced vaccination programmes with varying access and coverage, but are often faced with \n cultural, social, financial and political barriers.","bbox":{"left":0.12105,"top":0.284691,"width":0.7579250000000001,"height":0.16137799999999997}},{"text":"IFMSA position: \n As the leading cause of cervical cancer, and a significant cause of many others, attention given to the \n supply and administration of HPV vaccines is insufficient. IFMSA believes that young people of all \n genders must be vaccinated, which will reduce population HPV prevalence and therefore the incidence \n of HPV related diseases. Increased access to vaccination through fair pricing is essential to allow all \n WHO member states to reduce preventable deaths and morbidity. \n Call to Action: \n Therefore, IFMSA calls on: \n WHO Member States to: \n 1. Ensure that their entire population has access to HPV vaccination at a young age \n 2. Add HPV to the regular vaccination schedule for children \n 3. Promote HPV vaccination in conjunction with cervical screening programmes and \n recognise the importance of these combined public health initiatives in reducing the \n burden of HPV-associated diseases \n 4. Employ routine cervical cancer screening for the general population via Pap smears \n and utilising HPV DNA co-testing to increase cost-effectiveness and improve patient \n outcomes \n 5. Utilise health promotion campaigns to alert the public to risk factors and reduce \n vaccination hesitancy, encouraging increased uptake of the vaccine \n International Organisations and NGOs to:","bbox":{"left":0.12105,"top":0.471235,"width":0.7580250000000001,"height":0.358497}},{"text":"1.","bbox":{"left":0.211849,"top":0.839014,"width":0.013916000000000012,"height":0.016317999999999944}},{"text":"Utilise health promotion campaigns to alert the public to risk factors and reduce \n vaccination hesitancy, encouraging increased uptake of the vaccine \n Create campaigns that focus on the deconstruction of the stigma surrounding HPV \n vaccinations and gender-neutral vaccinations","bbox":{"left":0.242101,"top":0.839014,"width":0.612251,"height":0.057321999999999984}},{"text":"2.","bbox":{"left":0.211849,"top":0.866354,"width":0.013916000000000012,"height":0.016317999999999944}},{"text":"IFMSA International Secretariat, c/o IMCC, Nørre Allé 14, 2200 København N., Denmark","bbox":{"left":0.097521,"top":0.948085,"width":0.6261650000000001,"height":0.015502000000000016}}],"images_bbox":[],"images_bbox_not_text_overlap":[]}